Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Classical Immunoproteomics: Serological Proteome Analysis (SERPA) for Antigen Identification.

Fulton KM, Ananchenko A, Wolfraim L, Martin S, Twine SM.

Methods Mol Biol. 2019;2024:59-78. doi: 10.1007/978-1-4939-9597-4_3.

PMID:
31364042
2.

The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Guina T, Lanning LL, Omland KS, Williams MS, Wolfraim LA, Heyse SP, Houchens CR, Sanz P, Hewitt JA.

Front Cell Infect Microbiol. 2018 Apr 4;8:99. doi: 10.3389/fcimb.2018.00099. eCollection 2018.

3.

Methods and applications of serological proteome analysis.

Fulton KM, Martin SS, Wolfraim L, Twine SM.

Methods Mol Biol. 2013;1061:97-112. doi: 10.1007/978-1-62703-589-7_5.

PMID:
23963932
4.

Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL.

Wolfraim LA, Takahara M, Viley AM, Shivakumar R, Nieda M, Maekawa R, Liu LN, Peshwa MV.

Int Immunopharmacol. 2013 Mar;15(3):488-97. doi: 10.1016/j.intimp.2013.01.009. Epub 2013 Feb 8.

PMID:
23474736
5.

Signatures of T cells as correlates of immunity to Francisella tularensis.

Eneslätt K, Normark M, Björk R, Rietz C, Zingmark C, Wolfraim LA, Stöven S, Sjöstedt A.

PLoS One. 2012;7(3):e32367. doi: 10.1371/journal.pone.0032367. Epub 2012 Mar 6.

6.

Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination.

Fulton KM, Zhao X, Petit MD, Kilmury SL, Wolfraim LA, House RV, Sjostedt A, Twine SM.

Int J Med Microbiol. 2011 Nov;301(7):591-601. doi: 10.1016/j.ijmm.2011.07.002. Epub 2011 Aug 27.

7.

Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, Wolfraim LA, Tärnvik A, Sjöstedt A.

Eur J Immunol. 2011 Apr;41(4):974-80. doi: 10.1002/eji.201040923. Epub 2011 Feb 21.

8.

Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method.

Li L, Liu LN, Feller S, Allen C, Shivakumar R, Fratantoni J, Wolfraim LA, Fujisaki H, Campana D, Chopas N, Dzekunov S, Peshwa M.

Cancer Gene Ther. 2010 Mar;17(3):147-54. doi: 10.1038/cgt.2009.61. Epub 2009 Sep 11.

9.

Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation.

Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, Knight B, Yeoh GC, Fausto N, Parks WT.

Hepatology. 2007 Jan;45(1):31-41.

PMID:
17187411
10.

Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription.

Collins S, Wolfraim LA, Drake CG, Horton MR, Powell JD.

J Immunol. 2006 Dec 15;177(12):8301-5.

11.

Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.

Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Anver M, Wolfraim L, Hong S, Mushinski E, Potter M, Kim SJ, Fu XY, Deng C, Letterio JJ.

Nature. 2006 Jun 22;441(7096):1015-9. Erratum in: Nature. 2006 Dec 7;444(7120):780. Kasperczak, Barbara [corrected to Kasprzak, Barbara].

PMID:
16791201
12.

Treating autoimmune diseases through restoration of antigen-specific immune tolerance.

Wolfraim LA.

Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):1-13. Epub 2006 Jan 23. Review.

PMID:
16642252
13.

Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.

Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW.

Mol Ther. 2006 Jan;13(1):42-8. Epub 2005 Oct 10.

15.
16.

Loss of Smad3 in acute T-cell lymphoblastic leukemia.

Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ.

N Engl J Med. 2004 Aug 5;351(6):552-9.

17.

Development and application of fully functional epitope-tagged forms of transforming growth factor-beta.

Wolfraim LA, Alkemade GM, Alex B, Sharpe S, Parks WT, Letterio JJ.

J Immunol Methods. 2002 Aug 1;266(1-2):7-18.

PMID:
12133618
18.

The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells.

Qu Z, Wolfraim LA, Svaren J, Ehrengruber MU, Davidson N, Milbrandt J.

J Cell Biol. 1998 Aug 24;142(4):1075-82.

19.

Characterization of the TATA-less core promoter of the cell cycle-regulated cdc25C gene.

Körner K, Wolfraim LA, Lucibello FC, Müller R.

Nucleic Acids Res. 1997 Dec 15;25(24):4933-9.

20.

CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.

Liu N, Lucibello FC, Körner K, Wolfraim LA, Zwicker J, Müller R.

Nucleic Acids Res. 1997 Dec 15;25(24):4915-20.

21.

Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression.

Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, Müller R.

EMBO J. 1995 Sep 15;14(18):4514-22.

22.

Differential expression of S1 and elongation factor-1 alpha during rat development.

Lee S, Wolfraim LA, Wang E.

J Biol Chem. 1993 Nov 15;268(32):24453-9.

23.

Cloning and sequencing of the cDNA for cas17, a cold acclimation-specific gene of alfalfa.

Wolfraim LA, Dhindsa RS.

Plant Physiol. 1993 Oct;103(2):667-8. No abstract available.

24.
25.

Molecular cloning and relationship to freezing tolerance of cold-acclimation-specific genes of alfalfa.

Mohapatra SS, Wolfraim L, Poole RJ, Dhindsa RS.

Plant Physiol. 1989 Jan;89(1):375-80.

Supplemental Content

Loading ...
Support Center